Search results for "Hepatitis"
Spotlight on mortality trends in liver disease
One study looked at 10-year U.S. mortality trends related to chronic liver diseases, while another assessed mortality from cirrhosis and liver cancer in the U.S. from 1999 to 2016.
https://gastroenterology.acponline.org/archives/2018/07/27/5.htm
27 Jul 2018
Spotlight on screening in primary care
Patient-specific reminders for clinicians performed best for increasing colorectal cancer screening in a French study, while an EHR alert appeared to successfully increase hepatitis C virus screening rates for baby boomers in a U.S. health care system.
https://gastroenterology.acponline.org/archives/2017/09/22/5.htm
22 Sep 2017
Prophylactic HCV treatment with direct-acting antivirals appears safe in noninfected kidney recipients
Researchers studied 10 HCV-negative recipients of 10 HCV-positive donor kidneys in an open-label, nonrandomized trial.
https://gastroenterology.acponline.org/archives/2018/03/23/3.htm
23 Mar 2018
ACG guidelines advise on diagnosis, treatment of alcoholic liver disease
Patients with heavy alcohol use should be counseled that they are at increased risk for alcoholic liver disease, among other recommendations from the American College of Gastroenterology.
https://gastroenterology.acponline.org/archives/2018/01/26/1.htm
26 Jan 2018
Project ECHO model appears cost-effective for HCV diagnosis, treatment
The incremental cost-effectiveness ratio with Project ECHO versus usual care was $10,351 per QALY, with 95.6% of iterations falling below a willingness-to-pay threshold of $50,000 per QALY and more than 99.9% falling below a willingness-to-pay threshold of $100,000 per QALY.
https://gastroenterology.acponline.org/archives/2017/11/28/3.htm
28 Nov 2017
New HCV drug combo approved
The fixed-dose tablet combines the previously approved drugs sofosbuvir and velpatasvir with a new drug, voxilaprevir.
https://gastroenterology.acponline.org/archives/2017/07/28/10.htm
28 Jul 2017
Nearly all patients in study achieved sustained virologic response after 12 weeks of new HCV treatment
The drug combination appeared effective in adults with HCV genotypes 1, 2, 4, 5, or 6 infection and compensated cirrhosis in the industry-funded trial.
https://gastroenterology.acponline.org/archives/2017/08/25/3.htm
25 Aug 2017
Spotlight on statin therapy
Studies published in May found a potential benefit of statin therapy for three different conditions.
https://gastroenterology.acponline.org/archives/2017/05/26/5.htm
26 May 2017
HCV treatment by NPs, PCPs appears safe, effective as that provided by subspecialists
Reversing insurance restrictions that limit prescribing of direct-acting antivirals might allow rapid escalation of safe, effective therapy for hepatitis C virus (HCV) infection and could improve the care of patients, study authors noted.
https://gastroenterology.acponline.org/archives/2017/08/25/6.htm
25 Aug 2017
Study finds substantial increase in HCV infection among younger women, children
Data from the National Notifiable Diseases Surveillance System and the Quest Diagnostics Health Trends database were used to estimate the incidence of hepatitis C virus (HCV) infection among women ages 15 to 44 years and children ages 2 to 13 years.
https://gastroenterology.acponline.org/archives/2017/05/26/1.htm
26 May 2017